The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
The Dystrophin Complex: Structure, Function, and Implications for Therapy
Open accessAbstract
The dystrophin complex stabilizes the plasma membrane of striated muscle cells. Loss of function mutations in the genes encoding dystrophin, or the associated proteins, trigger instability of the plasma membrane, and myofiber loss. Mutations in dystrophin have been extensively cataloged, providing remarkable structure-function correlation between predicted protein structure and clinical outcomes. These data have highlighted dystrophin regions necessary for in vivo function and fueled the design of viral vectors and now, exon skipping approaches for use in dystrophin restoration therapies. However, dystrophin restoration is likely more complex, owing to the role of the dystrophin complex as a broad cytoskeletal integrator. This review will focus on dystrophin restoration, with emphasis on the regions of dystrophin essential for interacting with its associated proteins and discuss the structural implications of these approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcium's Role in Mechanotransduction during Muscle Development
Benavides Damm, T., & Egli, M. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000356667 · Cited by 14,502
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693 · cited 1×
“DMD is caused by recessive mutations in the dystrophin gene on X chromosome, affecting 1 in 3,500 to 5,000 newborn males worldwide (82).”
Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90504-6 · Cited by 2,411
Prevalence of Muscular Dystrophies: A Systematic Literature Review
Theadom, A., Rodrigues, M., Roxburgh, R., Balalla, S., Higgins, C., Bhattacharjee, R., Jones, K., Krishnamurthi, R., & Feigin, V. (2014) · Neuroepidemiology · doi:10.1159/000369343 · Cited by 2,046
Brenman, J. E., Chao, D. S., Gee, S. H., McGee, A. W., Craven, S. E., Santillano, D. R., Wu, Z., Huang, F., Xia, H., Peters, M. F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81053-3 · Cited by 1,596
The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein
Koenig, M., Monaco, A. P., & Kunkel, L. M. (1988) · Cell · doi:10.1016/0092-8674(88)90383-2 · Cited by 1,538
Dystrophin protects the sarcolemma from stresses developed during muscle contraction
Petrof, B. J., Shrager, J. B., Stedman, H. H., Kelly, A. M., & Sweeney, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3710 · Cited by 1,526
Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., & Campbell, K. P. (1992) · Nature · doi:10.1038/355696a0 · Cited by 1,410
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin
Ervasti, J., & Campbell, K. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.4.809 · Cited by 1,388
Targeted disruption of the neuronal nitric oxide synthase gene
Huang, P. L., Dawson, T. M., Bredt, D. S., Snyder, S. H., & Fishman, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90615-w · Cited by 1,303
Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., & Campbell, K. P. (1990) · Nature · doi:10.1038/345315a0 · Cited by 1,025
Filamins as integrators of cell mechanics and signalling
Stossel, T. P., Condeelis, J., Cooley, L., Hartwig, J. H., Noegel, A., Schleicher, M., & Shapiro, S. S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35052082 · Cited by 1,020
Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., Müller, C. R., Lindlöf, M., Kääriäinen, H. A., et al. (1989) · Europe PMC (PubMed Central) · Cited by 961
Aplin, A. E., Howe, A., Alahari, S. K., & Juliano, R. L. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01359-0 · Cited by 847
Post-translational disruption of dystroglycan–ligand interactions in congenital muscular dystrophies
Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., et al. (2002) · Nature · doi:10.1038/nature00837 · Cited by 779
Utrophin–dystrophin-deficient mice as a model for Duchenne muscular dystrophy
Deconinck, A. E., Rafael, J. A., Skinner, J. A., Brown, S. C., Potter, A. C., Metzinger, L., Watt, D. J., Dickson, J. G., Tinsley, J. M., & Davies, K. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80532-2 · Cited by 752
Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
Goemans, N. M., Tulinius, M., van den Akker, J. T., Burm, B. E., Ekhart, P. F., Heuvelmans, N., Holling, T., Janson, A. A., Platenburg, G. J., Sipkens, J. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011367 · Cited by 678
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin
England, S. B., Nicholson, L. V. B., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-Gaarn, E. E., Bulman, D. E., Harris, J. B., & Davies, K. E. (1990) · Nature · doi:10.1038/343180a0 · Cited by 623
Expression of full-length utrophin prevents muscular dystrophy in mdx mice
Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.-M., & Davies, K. (1998) · Nature Medicine · doi:10.1038/4033 · Cited by 615
Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy
Harper, S. Q., Hauser, M. A., DelloRusso, C., Duan, D., Crawford, R. W., Phelps, S. F., Harper, H. A., Robinson, A. S., Engelhardt, J. F., Brooks, S. V., et al. (2002) · Nature Medicine · doi:10.1038/nm0302-253 · Cited by 579
Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome
Ichida, F., Tsubata, S., Bowles, K. R., Haneda, N., Uese, K., Miyawaki, T., Dreyer, W. J., Messina, J., Li, H., Bowles, N. E., et al. (2001) · Circulation · doi:10.1161/01.cir.103.9.1256 · Cited by 557
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Harada, H., Andersen, J. S., Mann, M., Terada, N., & Korsmeyer, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171301998 · Cited by 549
Williamson, R. A., Henry, M. D., Daniels, K. J., Hrstka, R. F., Lee, J. C., Sunada, Y., Ibraghimov-Beskrovnaya, O., & Campbell, K. P. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.6.831 · Cited by 541
Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor
Gee, S. H., Montanaro, F., Lindenbaum, M. H., & Carbonetto, S. (1994) · Cell · doi:10.1016/0092-8674(94)90052-3 · Cited by 512
Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome
Zimprich, A., Grabowski, M., Asmus, F., Naumann, M., Berg, D., Bertram, M., Scheidtmann, K., Kern, P., Winkelmann, J., Müller-Myhsok, B., et al. (2001) · Nature Genetics · doi:10.1038/ng709 · Cited by 487
Talts, J. F., Andac, Z., Göhring, W., Brancaccio, A., & Timpl, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.4.863 · Cited by 454
Longman, C. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg307 · Cited by 416
Koenig, M., & Kunkel, L. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39599-7 · Cited by 403
Lai, Y., Thomas, G. D., Yue, Y., Yang, H. T., Li, D., Long, C., Judge, L., Bostick, B., Chamberlain, J. S., Terjung, R. L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36612 · Cited by 389
Tuffery-Giraud, S., Béroud, C., Leturcq, F., Yaou, R. B., Hamroun, D., Michel-Calemard, L., Moizard, M.-P., Bernard, R., Cossée, M., Boisseau, P., et al. (2009) · Human Mutation · doi:10.1002/humu.20976 · Cited by 377
Thomas, G. D., Sander, M., Lau, K. S., Huang, P. L., Stull, J. T., & Victor, R. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.15090 · Cited by 376
Flanigan, K. M., Dunn, D. M., von Niederhausern, A., Soltanzadeh, P., Gappmaier, E., Howard, M. T., Sampson, J. B., Mendell, J. R., Wall, C., King, W. M., et al. (2009) · Human Mutation · doi:10.1002/humu.21114 · Cited by 321
Role for α-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies
Grady, R. M., Grange, R. W., Lau, K. S., Maimone, M. M., Nichol, M. C., Stull, J. T., & Sanes, J. R. (1999) · Nature Cell Biology · doi:10.1038/12034 · Cited by 314
Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein
Thompson, T. G., Chan, Y.-M., Hack, A. A., Brosius, M., Rajala, M., Lidov, H. G. W., McNally, E. M., Watkins, S., & Kunkel, L. M. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.115 · Cited by 294
Self-citationImproved diagnosis of Becker muscular dystrophy by dystrophin testing
Hoffman, E. P., Kunkel, L. M., Angelini, C., Clarke, A., Johnson, M., & Harris, J. B. (1989) · Neurology · doi:10.1212/wnl.39.8.1011 · Cited by 291
Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice
Phelps, S. F., Hauser, M. A., Cole, N. M., Rafael, J. A., Hinkle, R. T., Faulkner, J. A., & Chamberlain, J. S. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1251 · Cited by 288
Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy
Jefferies, J. L., Eidem, B. W., Belmont, J. W., Craigen, W. J., Ware, S. M., Fernbach, S. D., Neish, S. R., Smith, E. O., & Towbin, J. A. (2005) · Circulation · doi:10.1161/circulationaha.104.528281 · Cited by 288
γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin
Hack, A. A., Ly, C. T., Jiang, F., Clendenin, C. J., Sigrist, K. S., Wollmann, R. L., & McNally, E. M. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.5.1279 · Cited by 286
Self-citationA Dystroglycan Mutation Associated with Limb-Girdle Muscular Dystrophy
Hara, Y., Balci-Hayta, B., Yoshida-Moriguchi, T., Kanagawa, M., Beltrán-Valero de Bernabé, D., Gündeşli, H., Willer, T., Satz, J. S., Crawford, R. W., Burden, S. J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1006939 · Cited by 283
Maturation and Maintenance of the Neuromuscular Synapse
Grady, R. M., Zhou, H., Cunningham, J. M., Henry, M. D., Campbell, K. P., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)80894-6 · Cited by 281
High glucose induces adipogenic differentiation of muscle-derived stem cells
Aguiari, P., Leo, S., Zavan, B., Vindigni, V., Rimessi, A., Bianchi, K., Franzin, C., Cortivo, R., Rossato, M., Vettor, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711402105 · Cited by 279
Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy
Khairallah, R. J., Shi, G., Sbrana, F., Prosser, B. L., Borroto, C., Mazaitis, M. J., Hoffman, E. P., Mahurkar, A., Sachs, F., Sun, Y., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002829 · Cited by 259
HORNBERGER, T. A., STUPPARD, R., CONLEY, K. E., FEDELE, M. J., FIOROTTO, M. L., CHIN, E. R., & ESSER, K. A. (2004) · Biochemical Journal · doi:10.1042/bj20040274 · Cited by 256
SH3 Domain-mediated Interaction of Dystroglycan and Grb2
Yang, B., Jung, D., Motto, D., Meyer, J., Koretzky, G., & Campbell, K. P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11711 · Cited by 254
Eccentric muscle damage: mechanisms of early reduction of force
Allen, D. G. (2001) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.2001.00833.x · Cited by 245
Willer, T., Lee, H., Lommel, M., Yoshida-Moriguchi, T., de Bernabe, D. B. V., Venzke, D., Cirak, S., Schachter, H., Vajsar, J., Voit, T., et al. (2012) · Nature Genetics · doi:10.1038/ng.2252 · Cited by 238
Genetic basis of limb-girdle muscular dystrophies: the 2014 update.
Nigro, V., & Savarese, M. (2014) · Europe PMC (PubMed Central) · Cited by 238
Porter, G., Dmytrenko, G., Winkelmann, J., & Bloch, R. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.5.997 · Cited by 233
Carss, K. J., Stevens, E., Foley, A. R., Cirak, S., Riemersma, M., Torelli, S., Hoischen, A., Willer, T., van Scherpenzeel, M., Moore, S. A., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.05.009 · Cited by 233
Absence of α-Syntrophin Leads to Structurally Aberrant Neuromuscular Synapses Deficient in Utrophin
Adams, M. E., Kramarcy, N., Krall, S. P., Rossi, S. G., Rotundo, R. L., Sealock, R., & Froehner, S. C. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.6.1385 · Cited by 230
A new model for the interaction of dystrophin with F-actin.
Rybakova, I. N., Amann, K. J., & Ervasti, J. M. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.3.661 · Cited by 220
Muscular dystrophies: genes to pathogenesis
Dalkilic, I., & Kunkel, L. M. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00048-0 · Cited by 220
Dystrobrevin and dystrophin: An interaction through coiled-coil motifs
Sadoulet-Puccio, H. M., Rajala, M., & Kunkel, L. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12413 · Cited by 217
The dystrophin–glycoprotein complex in brain development and disease
Waite, A., Brown, S. C., & Blake, D. J. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.04.004 · Cited by 215
YOSHIDA, M., SUZUKI, A., YAMAMOTO, H., NOGUCHI, S., MIZUNO, Y., & OZAWA, E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18958.x · Cited by 212
Caveolin-3 Directly Interacts with the C-terminal Tail of β-Dystroglycan
Sotgia, F., Lee, J. K., Das, K., Bedford, M., Petrucci, T. C., Macioce, P., Sargiacomo, M., Bricarelli, F. D., Minetti, C., Sudol, M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005321200 · Cited by 212
Altered expression of the α7β1 integrin in human and murine muscular dystrophies
Hodges, B. L., Hayashi, Y. K., Nonaka, I., Wang, W., Arahata, K., & Kaufman, S. J. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.22.2873 · Cited by 211
Dystrophin is a microtubule-associated protein
Prins, K. W., Humston, J. L., Mehta, A., Tate, V., Ralston, E., & Ervasti, J. M. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200905048 · Cited by 210
Béroud, C., Tuffery-Giraud, S., Matsuo, M., Hamroun, D., Humbertclaude, V., Monnier, N., Moizard, M.-P., Voelckel, M.-A., Calemard, L. M., Boisseau, P., et al. (2007) · Human Mutation · doi:10.1002/humu.20428 · Cited by 207
Sarcospan, the 25-kDa Transmembrane Component of the Dystrophin-Glycoprotein Complex
Crosbie, R. H., Heighway, J., Venzke, D. P., Lee, J. C., & Campbell, K. P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31221 · Cited by 206
ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins
Ponting, C. P., Blake, D. J., Davies, K. E., Kendrick-Jones, J., & Winder, S. J. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(06)80020-4 · Cited by 204
Hack, A. A., Lam, M.-Y. J., Cordier, L., Shoturma, D. I., Ly, C. T., Hadhazy, M. A., Hadhazy, M. R., Sweeney, H. L., & McNally, E. M. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.14.2535 · Cited by 197
Self-citationDanialou, G., Comtois, A. S., Dudley, R., Karpati, G., Vincent, G., Des Rosiers, C., & Petrof, B. J. (2001) · The FASEB Journal · doi:10.1096/fj.01-0030fje · Cited by 185
The WW domain: Linking cell signalling to the membrane cytoskeleton
Ilsley, J. L., Sudol, M., & Winder, S. J. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00236-4 · Cited by 183
Caveolae and caveolin-3 in muscular dystrophy
Galbiati, F., Razani, B., & Lisanti, M. P. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02105-0 · Cited by 168
Dystroglycan, a scaffold for the ERK–MAP kinase cascade
Spence, H. J., Dhillon, A. S., James, M., & Winder, S. J. (2004) · EMBO reports · doi:10.1038/sj.embor.7400140 · Cited by 164
Emerging Role for ERK as a Key Regulator of Neuronal Apoptosis
Cheung, E. C. C., & Slack, R. S. (2004) · Science's STKE · doi:10.1126/stke.2512004pe45 · Cited by 162
Araishi, K., Sasaoka, T., Imamura, M., Noguchi, S., Hama, H., Wakabayashi, E., Yoshida, M., Hori, T., & Ozawa, E. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1589 · Cited by 161
Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery
Aoki, Y., Yokota, T., Nagata, T., Nakamura, A., Tanihata, J., Saito, T., Duguez, S. M. R., Nagaraju, K., Hoffman, E. P., Partridge, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204638109 · Cited by 160
Calponin homology domains at a glance
Korenbaum, E., & Rivero, F. (2002) · Journal of Cell Science · doi:10.1242/jcs.00003 · Cited by 159
Wagner, K. R., Cohen, J. B., & Huganir, R. L. (1993) · Neuron · doi:10.1016/0896-6273(93)90338-r · Cited by 159
Microtubule binding distinguishes dystrophin from utrophin
Belanto, J. J., Mader, T. L., Eckhoff, M. D., Strandjord, D. M., Banks, G. B., Gardner, M. K., Lowe, D. A., & Ervasti, J. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323842111 · Cited by 158
Stress-activated Protein Kinase-3 Interacts with the PDZ Domain of α1-Syntrophin
Hasegawa, M., Cuenda, A., Spillantini, M. G., Thomas, G. M., Buée-Scherrer, V., Cohen, P., & Goedert, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12626 · Cited by 158
Muscle Diseases: The Muscular Dystrophies
McNally, E. M., & Pytel, P. (2007) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.2.010506.091936 · Cited by 158
Self-citationKaspar, R. W., Allen, H. D., Ray, W. C., Alvarez, C. E., Kissel, J. T., Pestronk, A., Weiss, R. B., Flanigan, K. M., Mendell, J. R., & Montanaro, F. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.867242 · Cited by 157
An Ankyrin-Based Mechanism for Functional Organization of Dystrophin and Dystroglycan
Ayalon, G., Davis, J. Q., Scotland, P., & Bennett, V. (2008) · Cell · doi:10.1016/j.cell.2008.10.018 · Cited by 155
Membrane Targeting and Stabilization of Sarcospan Is Mediated by the Sarcoglycan Subcomplex
Crosbie, R. H., Lebakken, C. S., Holt, K. H., Venzke, D. P., Straub, V. W., Lee, J. C., Grady, R. M., Chamberlain, J. S., Sanes, J. R., & Campbell, K. P. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.1.153 · Cited by 154
Anthony, K., Çırak, S., Torelli, S., Tasca, G. A., Feng, L., Arechavala‐Gomeza, V., Armaroli, A., Guglieri, M., Straathof, C. S. M., Verschuuren, J. J. G. M., et al. (2011) · Brain · doi:10.1093/brain/awr291 · Cited by 152
Expression of the N‐terminal domain of dystrophin in E. coli and demonstration of binding to F‐actin
Way, M., Pope, B. J., Cross, R. A., Kendrick‐Jones, J., & Weeds, A. G. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80249-g · Cited by 149
Yoshida, T., Pan, Y., Hanada, H., Iwata, Y., & Shigekawa, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1583 · Cited by 146
Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker–Warburg syndrome
Buysse, K., Riemersma, M., Powell, G. T., van Reeuwijk, J., Chitayat, D. A., Roscioli, T., Kamsteeg, E., van den Elzen, C., van Beusekom, E., Blasér, S., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt021 · Cited by 146
Electron microscopic evidence for a mucin‐like region in chick muscle α‐dystroglycan
Brancaccio, A., Schulthess, T., Gesemann, M., & Engel, J. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00628-m · Cited by 145
The WW Domain of Dystrophin Requires EF-Hands Region to Interact with β-Dystroglycan
Rentschler, S., Linn, H., Deininger, K. C., Bedford, M. T., Espanel, X., & Sudol, M. (1999) · Biological Chemistry · doi:10.1515/bc.1999.057 · Cited by 144
Yoshida, M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.7.1033 · Cited by 141
Spectrin, α-Actinin, and Dystrophin
Broderick, M., & Winder, S. J. (2005) · Advances in protein chemistry · doi:10.1016/s0065-3233(05)70007-3 · Cited by 137
Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture
Chan, Y., Bonnemann, C., Lidov, H., & Kunkel, L. (1998) · Journal of Cell Biology · doi:10.1083/jcb.143.7.2033 · Cited by 132
Dystrophin levels and clinical severity in Becker muscular dystrophy patients
van den Bergen, J. C., Wokke, B. H. A., Janson, A. A., van Duinen, S. G., Hulsker, M., Ginjaar, H. B., van Deutekom, J. C., Aartsma-Rus, A. M., Kan, H. E., & Verschuuren, J. J. G. M. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306350 · Cited by 126
Wein, N., Vulin, A., Falzarano, M. S., Szigyarto, C. A., Maiti, B., Findlay, A. R., Heller, K. N., Uhlén, M., Bakthavachalu, B., Messina, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3628 · Cited by 124
Muscle degeneration without mechanical injury in sarcoglycan deficiency
Hack, A. A., Cordier, L., Shoturma, D. I., Lam, M. Y., Sweeney, H. L., & McNally, E. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10723 · Cited by 120
Self-citationFlanigan, K. M., Dunn, D. M., von Niederhausern, A. C., Soltanzadeh, P., Howard, M. T., Sampson, J. B., Swoboda, K. J., Bromberg, M. B., Mendell, J. R., Taylor, L. E., et al. (2010) · Human Mutation · doi:10.1002/humu.21426 · Cited by 119
Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster
Straub, V. W., Duclos, F. J., Venzke, D. P., Lee, J. C., Cutshall, S., Leveille, C. J., & Campbell, K. P. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65751-3 · Cited by 115
van Putten, M., Hulsker, M., Young, C. S., Nadarajah, V. D., Heemskerk, H., van der Weerd, L., Hoen, P. A. C. ’., van Ommen, G. B., & Aartsma-Rus, A. M. (2013) · The FASEB Journal · doi:10.1096/fj.12-224170 · Cited by 115
Guo, C., Willem, M., Werner, A., Raivich, G., Emerson, M., Neyses, L., & Mayer, U. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl018 · Cited by 114
Hara, Y., Kanagawa, M., Kunz, S., Yoshida‐Moriguchi, T., Satz, J. S., Kobayashi, Y. M., Zhu, Z., Burden, S. J., Oldstone, M. B. A., & Campbell, K. P. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114836108 · Cited by 113
Willer, T., Amselgruber, W. M., Deutzmann, R., & Strahl, S. (2002) · Glycobiology · doi:10.1093/glycob/cwf086 · Cited by 110
BLAKE, D., Tinsley, J. M., Davies, K. J. A., Knight, A. E., Winder, S. J., & Kendrick‐Jones, J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)88986-0 · Cited by 109
Calpain 3 cleaves filamin C and regulates its ability to interact with γ‐ and δ‐sarcoglycans
Guyon, J. R., Kudryashova, E., Potts, A., Dalkilic, I., Brosius, M. A., Thompson, T. G., Beckmann, J. S., Kunkel, L. M., & Spencer, M. J. (2003) · Muscle & Nerve · doi:10.1002/mus.10465 · Cited by 102
zeta-Sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy
Wheeler, M. T. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2147 · Cited by 100
Newey, S. E., Benson, M. A., Ponting, C. P., Davies, K. E., & Blake, D. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00760-0 · Cited by 99
Crosbie, R. H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.2019 · Cited by 98
Anthony, K., Arechavala‐Gomeza, V., Ricotti, V., Torelli, S., Feng, L., Janghra, N., Tasca, G. A., Guglieri, M., Barresi, R., Armaroli, A., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4908 · Cited by 97
Interactions of intermediate filament protein synemin with dystrophin and utrophin
Bhosle, R., Michele, D. E., Campbell, K. P., Li, Z., & Robson, R. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.192 · Cited by 96
Zhang, Y., & Duan, D. (2012) · Human Gene Therapy · doi:10.1089/hum.2011.131 · Cited by 95
Stone, M. R., O’Neill, A., Lovering, R. M., Strong, J. C., Resneck, W. G., Reed, P. W., Toivola, D. M., Ursitti, J. A., Omary, M. B., & Bloch, R. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.009241 · Cited by 94
Stone, M. R., O’Neill, A., Catino, D. H., & Bloch, R. J. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0112 · Cited by 94
Ginjaar, I. B., Kneppers, A. L. J., Meulen, J.-D. M. V. D., Anderson, L. V. B., Bremmer-Bout, M., van Deutekom, J. C., Weegenaar, J., den Dunnen, J. T., & Bakker, E. (2000) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200535 · Cited by 92
Nakamura, A., Yoshida, K., Fukushima, K., Ueda, H., Urasawa, N., Koyama, J., Yazaki, Y., Yazaki, M., Sakai, T., Haruta, S., et al. (2008) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2006.12.012 · Cited by 92
Singh, S. M., Narsimulu, K., Cabello‐Villegas, J., & Mallela, K. M. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008818107 · Cited by 90
Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle.
Barton, E. (2006) · American Journal of Physiology - Cell Physiology · doi:10.1152/ajpcell.00192.2005 · Cited by 90
Tyrosine-phosphorylated and nonphosphorylated isoforms of α-dystrobrevin
Grady, R. M., Akaaboune, M., Cohen, A. L., Maimone, M. M., Lichtman, J. W., & Sanes, J. R. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200209045 · Cited by 90
The Polyproline Site in Hinge 2 Influences the Functional Capacity of Truncated Dystrophins
Banks, G. B., Judge, L. M., Allen, J. M., & Chamberlain, J. S. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000958 · Cited by 89
POMT1 mutation results in defective glycosylation and loss of laminin-binding activity in α-DG
Kim, D. S., Hayashi, Y. K., Matsumoto, H., Ogawa, M., Noguchi, S., Murakami, N., SAKUTA, R., Mochizuki, M., Michele, D. E., Campbell, K. P., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000115386.28769.65 · Cited by 88
Molecular deletion patterns in Duchenne and Becker type muscular dystrophy
Liechti‐Gallati, S., Koenig, M., Kunkel, L. M., Frey, D., Boltshauser, E., Schneider, V., Braga, S., & Moser, H. R. (1989) · Human Genetics · doi:10.1007/bf00283688 · Cited by 86
Butler, M. H., Douville, K. L., Murnane, A. A., Kramarcy, N. R., Cohen, J. B., Sealock, R. W., & Froehner, S. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42683-x · Cited by 84
Athanasopoulos, T., Graham, I., Foster, H., & Dickson, G. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302379 · Cited by 82
Sarcospan-Deficient Mice Maintain Normal Muscle Function
Lebakken, C. S., Venzke, D. P., Hrstka, R. F., Consolino, C. M., Faulkner, J. A., Williamson, R. A., & Campbell, K. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1669-1677.2000 · Cited by 82
Yue, Y., Liu, M., & Duan, D. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.007 · Cited by 78
Sarcospan: a small protein with large potential for Duchenne muscular dystrophy
Marshall, J. L., & Crosbie, R. H. (2013) · Skeletal Muscle · doi:10.1186/2044-5040-3-1 · Cited by 75
An intact cysteine-rich domain is required for dystrophin function.
Bies, R. D., Caskey, C. T., & Fenwick, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115909 · Cited by 72
Ca2⁺-Calmodulin Binds to the Carboxyl-terminal Domain of Dystrophin
Anderson, J. T., Rogers, R. P., & Jarrett, H. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6605 · Cited by 69
Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle
Allikian, M. J., Hack, A. A., Mewborn, S. K., Mayer, U., & McNally, E. M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01234 · Cited by 68
Self-citationSpecific assembly pathway of sarcoglycans is dependent on beta‐ and delta‐sarcoglycan
Shi, W., Chen, Z., Schottenfeld, J., Stahl, R. C., Kunkel, L. M., & Chan, Y.-M. M. (2004) · Muscle & Nerve · doi:10.1002/mus.10566 · Cited by 67
The N‐terminal Region of α‐Dystroglycan is an Autonomous Globular Domain
Brancaccio, A., Schulthess, T., Gesemann, M., & Engel, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00166.x · Cited by 67
Kim, M. H., Kay, D. I., Rudra, R. T., Chen, B. M., Hsu, N., Izumiya, Y., Martinez, L., Spencer, M. J., Walsh, K. X., Grinnell, A. D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr015 · Cited by 67
Formation of sarcoglycan complex with differentiation in cultured myocytes
Noguchi, S., Wakabayashi‐Takai, E., Imamura, M., Yoshida, M., & Ozawa, E. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.00998.x · Cited by 64
Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain
Banks, G. B., Gregorevic, P., Allen, J. M., Finn, E. E., & Chamberlain, J. S. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm158 · Cited by 63
WW and EF Hand Domains of Dystrophin-Family Proteins Mediate Dystroglycan Binding
Chung, W. W., & Campanelli, J. T. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0168 · Cited by 61
Dressman, D. C., Araishi, K., Imamura, M., Sasaoka, T., Liu, L. A., Engvall, E., & Hoffman, E. P. (2002) · Human Gene Therapy · doi:10.1089/10430340260201725 · Cited by 61
Sarcospan reduces dystrophic pathology: stabilization of the utrophin–glycoprotein complex
Peter, A. K., Marshall, J. L., & Crosbie, R. H. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200808027 · Cited by 61
Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants
Allikian, M. J., Bhabha, G., Dospoy, P. D., Heydemann, A., Ryder, P. V., Earley, J. U., Wolf, M. J., Rockman, H. A., & McNally, E. M. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm254 · Cited by 61
Self-citationSarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration
Marshall, J. L., Holmberg, J., Chou, E., Ocampo, A. C., Oh, J., Lee, J., Peter, A. K., Martin, P. T., & Crosbie, R. H. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110032 · Cited by 59
Overexpression of γ-Sarcoglycan Induces Severe Muscular Dystrophy
Zhu, X., Hadhazy, M., Groh, M. E., Wheeler, M. T., Wollmann, R., & McNally, E. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101877200 · Cited by 56
Self-citationMarshall, J. L., Chou, E., Oh, J., Kwok, A., Burkin, D. J., & Crosbie, R. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds271 · Cited by 54
Genetic evidence for a dystrophin-glycoprotein complex (DGC) in Caenorhabditis elegans
Grisoni, K., Martin, E., Gieseler, K., Mariol, M., & Ségalat, L. (2002) · Gene · doi:10.1016/s0378-1119(02)00762-x · Cited by 53
Characterization of the ATP-hydrolysing activity of α-sarcoglycan
Sandonà, D., Gastaldello, S., Martinello, T., & Betto, R. (2004) · Biochemical Journal · doi:10.1042/bj20031644 · Cited by 50
Groh, S., Zong, H., Goddeeris, M. M., Lebakken, C. S., Venzke, D. P., Pessin, J. E., & Campbell, K. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.010728 · Cited by 48
Are cysteine-rich and COOH-terminal domains of dystrophin critical for sarcolemmal localization?
Récan, D., Chafey, P., Leturcq, F., Hugnot, J., Vincent, N., Tomé, F. M. S., Collin, H., Simon, D., Czernichow, P., & Nicholson, L. V. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115640 · Cited by 46
Banks, G. B., Combs, A. C., Chamberlain, J. R., & Chamberlain, J. S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn301 · Cited by 44
Ogawa, M., Nakamura, N., Nakayama, Y., Kurosaka, A., Manya, H., Kanagawa, M., Endo, T., Furukawa, K., & Okajima, T. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.09.022 · Cited by 41
Chen, J., Shi, W., Zhang, Y., Sokol, R. G., Cai, H., Lun, M., Moore, B. F., Farber, M. J., Stepanchick, J. S., Bönnemann, C. G., et al. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.01.024 · Cited by 38
-Sarcoglycan compensates for lack of -sarcoglycan in a mouse model of limb-girdle muscular dystrophy
Imamura, M., Mochizuki, Y., Engvall, E., & Takeda, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi072 · Cited by 38
Phosphorylation of dystrophin and α-syntrophin by Ca2+-calmodulin dependent protein kinase II
Madhavan, R., & Jarrett, H. W. (1999) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(99)00193-4 · Cited by 34
Peter, A. K., Miller, G., & Crosbie, R. H. (2007) · Journal of Cell Science · doi:10.1242/jcs.03360 · Cited by 34
Cassano, M., Dellavalle, A., Tedesco, F. S., Quattrocelli, M., Crippa, S., Ronzoni, F., Salvadè, A., Berardi, E., Torrente, Y., Cossu, G., et al. (2011) · Development · doi:10.1242/dev.070706 · Cited by 32
Vainzof, M., Takata, R. I., Passos‐Bueno, M. R., Pavanello, R. C. M., & Zatz, M. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.1.39 · Cited by 32
Increased adipogenicity of cells from regenerating skeletal muscle
Yamanouchi, K., Yada, E., Ishiguro, N., Hosoyama, T., & Nishihara, M. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.04.014 · Cited by 28
Enrichment of the R77C α‐sarcoglycan gene mutation in finnish LGMD2D patients
Hackman, P., Juvonen, V., Sarparanta, J., Penttinen, M. T., Äärimaa, T., Uusitalo, M., Auranen, M., Pihko, H. S., Alén, R., Junes, M., et al. (2004) · Muscle & Nerve · doi:10.1002/mus.20267 · Cited by 27
Griffin, M. A., Feng, H., Tewari, M., Acosta, P., Kawana, M., Sweeney, H. L., & Discher, D. E. (2005) · Journal of Cell Science · doi:10.1242/jcs.01717 · Cited by 26
Blake, D. J. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00091-3 · Cited by 26
Differential stabilities of alternative exon-skipped rod motifs of dystrophin
Ruszczak, C., Mirza, A. A., & Menhart, N. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.016 · Cited by 25
Hypoglycosylation of dystroglycan due to T192M mutation: A molecular insight behind the fact
Bhattacharya, S., Das, A., Ghosh, S., Dasgupta, R., & Bagchi, A. (2013) · Gene · doi:10.1016/j.gene.2013.11.071 · Cited by 24
Moorwood, C., Philippou, Α., Spinazzola, J. M., Keyser, B., Macarak, E. J., & Barton, E. R. (2014) · Skeletal Muscle · doi:10.1186/2044-5040-4-13 · Cited by 21
Barton, E. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063990 · Cited by 17
The 16 kDa subunit of vacuolar H+-ATPase is a novel sarcoglycan-interacting protein
Chen, J., Skinner, M. A., Shi, W., et al. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.01.014 · Cited by 12
Fanin, M., & Angelini, C. I. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00389.x · Cited by 4
Blaeser, A., Sparks, S. E., Brown, S., Campbell, K. P., & Lu, Q. L. (2014) · Brain Pathology · doi:10.1111/bpa.12118 · Cited by 2
Cited by
Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Wang, Y.-L., Lee, Y.-H., Hsu, Y.-H., Chiu, I.-J., Huang, C. C.-Y., Huang, C.-C., Chia, Z.-C., Lee, C.-P., Lin, Y.-F., & Chiu, H.-W. (2021) · Environmental Health Perspectives · doi:10.1289/ehp7612 · Cited by 383
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy
Lek, A., Wong, B., Keeler, A., Blackwood, M., Ma, K., Huang, S., Sylvia, K., Batista, A. R., Artinian, R., Kokoski, D., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2307798 · Cited by 319
In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges
Behr, M., Zhou, J., Xu, B., & Zhang, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.020 · Cited by 210
Innovative Therapeutic Approaches for Duchenne Muscular Dystrophy
Fortunato, F., Rossi, R., Falzarano, M. S., & Ferlini, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040820 · Cited by 64
Metadata
- Authors
- Gao, Q. Q., & McNally, E. M.
- Venue
- Comprehensive Physiology
- Publisher
- Wiley
- Published
- 2015-06-24
- Volume
- 5
- Issue
- 3
- Pages
- 1223-1239
- ISSN
- 2040-4603 (ISSN-L)
- OpenAlex
- W1850477203
- Cited by
- 456
- References
- 156
- Type
- other
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.